Acucela's Series B Round

Acucela raised a round of funding on November 15, 2004.

Acucela Inc. is a biotech company discovering drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and glaucoma, …

Articles about Acucela's Series B Round: